OAMIC Biotech (Xiamen) Co., Ltd., a provincial key industrial project, has achieved a milestone with the structural completion of its Phase II bioengineering facility in Haicang's Xinyang Industrial Zone Bio-Medicine Park. The project, covering 66,000 square meters with a floor area of 76,000 square meters, is scheduled for pre-acceptance in June 2025 and full operational launch by June 2026. Utilizing synthetic biology technologies, the facility will produce nutritional fortifiers for dietary supplements and healthcare applications, with an estimated annual output value of 2.8 billion yuan upon reaching full capacity. Founded in 2014, OAMIC specializes in R&D and application of synthetic biology and green chemistry technologies.
